Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
Conditions
- Relapsed/Refractory Multiple Myeloma
Interventions
- BIOLOGICAL: Anti-BCMA-GPRC5D CAR-T cells infusion
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Collaborators